Nina Gataric

Dr. Nina Gataric


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2025 in Medicina
Verified
Journal Article
Open access
PDF file
DSDejan S Simeunovic
Dejan S Simeunovic
IMIvan Milinkovic
Ivan Milinkovic
MPMarija M. Polovina
Marija M. Polovina
DTDanijela Trifunovic-Zamaklar
Danijela Trifunovic-Zamaklar
IZIvana Zivkovic
Ivana Zivkovic
PSPetar M. Seferović
Petar M. Seferović
Background and Objectives: Cardiac tamponade is managed through echo- or fluoroscopy-guided percutaneous pericardiocentesis. The European Society of Cardiology’s Working Group on Myocardial and Pericardial Diseases proposed a triage strategy for these patients. This study evaluated the triage score and compared the safety and efficacy of fluoroscopy- versus echo-guided procedures without additional visualization control. Materials and Methods: This prospective observational study included 71 patients with cardiac tamponade from February 2021 to June 2022. Pericardiocentesis was performed using fluoroscopy or echo guidance based on clinical assessment and catheterization laboratory availability, without the additional control of needle/guidewire position or ECG monitoring. Patients were followed for three months. Results: The study included 71 patients (52.1% female, mean age 59.7 ± 15.7 years). Malignancy was the most common comorbidity (59.2%). Echo criteria led to urgent procedures in 47.9%, with subcostal access used most often (60.6%), particularly in fluoroscopy-guided procedures (93.8%, p = 0.003). The success rate was 97.1%, with minor complications in 14% of patients. Diabetes and malignancy predicted complications regardless of access site or guiding method. The triage score did not affect complication rates or short-term mortality. Conclusions: Fluoroscopy- and echo-guided pericardiocentesis without additional visualization control showed no difference in safety or efficacy. Delaying the procedure for patients with a triage score ≥6, or performing it early for those with a low score, did not impact complication rates or mortality, which were more influenced by the progression of the underlying disease.

1 January 2025 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
DSDejan Simeunovic
Dejan Simeunovic
SJStefan Juricic
Stefan Juricic
NGNina Gataric
Nina Gataric
MRMarko Ristic
Marko Ristic
FSFilip Simeunovic
Filip Simeunovic
ARArsen Ristic
Arsen Ristic
Acute pericarditis arises from an inflammatory process affecting the pericardial tissue, leading to the subsequent formation of pericardial effusion as part of the body's inflammatory response. Cardiac tamponade occurs when a significant volume of fluid accumulates within the pericardial cavity, resulting in increased intrapericardial pressure and impaired diastolic filling, ultimately obstructing blood flow into the heart. Notably, even a relatively small pericardial effusion can precipitate tamponade, depending on the rate of fluid accumulation and the compliance of the pericardium. Pericardiocentesis remains the preferred intervention for the emergent management of patients presenting with cardiac tamponade. This procedure is typically performed via a subxiphoid or apical approach, with the selection of the access site guided by the distribution of the effusion as visualized on imaging. The timely execution of pericardiocentesis during the acute phase of tamponade is of paramount importance; failure to perform the procedure promptly may result in cardiovascular collapse, cardiac arrest, and ultimately, a potentially fatal outcome.

1 January 2021 in Medicinski podmladak
Verified
Journal Article
Open access
PDF file
NGNina Gataric
Nina Gataric
AIAna Ilić
Ana Ilić
Dušan TodorovićDušan Todorović
Dušan Todorović
SMSlavica Mutavdzin
Slavica Mutavdzin
JJJovana Jakovljević-Uzelac
Jovana Jakovljević-Uzelac
Dragan M DjuricDragan M Djuric
Dragan M Djuric
Introduction: Isoprenaline or isoproterenol (1-(3,4-dihydroxyphenyl)-2-isopropylaminoethanolhydrochloride; ISO), a synthetic b-adrenergic agonist, can be used to establish myocardial ischemia, cardiotoxicity, necrosis and/or an experimental model of infarction in rats. Aim: Determination of the dynamics of myocardial injury biomarkers production of aspartate transaminase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), and high-sensitive troponin T (hsTnT), with changes on electrocardiogram (ECG) parameters during the subcutaneous aplication of ISO in male Wistar rats. Material and methods: All animals (n = 23) were divided into two groups: control group (n = 11) treated with a saline solution, during two consecutive days (0,2 ml/kg b.m. daily, sc); and the ISO group (n = 12) treated with isoprenaline, during two consecutive days (85 mg/kg b.m. daily, sc). Blood was drawn from the rat tail vein in both groups, in order to determine serum activity levels of myocardial injury biomarkers, and an ECG (n = 6) was registered prior to the application, as well as 48h following the first dose of of saline solution or isoprenaline. Results: In comparison to the control group, in which no significant enzyme activities elevation (p > 0.05) nor ECG changes were registered, ISO group presented a significant rise of two clinically significant biomarkers of acute myocardial injury/myocardial infarction (AMI), CK (p = 0.05) and hsTnT (p < 0.01), as well as an ST segment elevation, with a patognomonic ECG change. Conclusion: Obtained results support previous studies, proving that isoprenaline represents an adequate experimental model for myocardial injury/AMI induction, and a "golden standard" for evaluating potential cardioprotective effects of pharmacological and non-pharmacological therapeutic modalities, with the ultimate goal of lowering the degree of lesions and improving post-infarction myocardium function.